FORTAZ (Cardinal Health)


Welcome to the PulseAid listing for the FORTAZ drug offered from Cardinal Health. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: ceftazidime
SUBSTANCE NAME: CEFTAZIDIME SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1992-08-26
END MARKETING DATE: 0000-00-00


FORTAZ HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFORTAZ from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 1992-08-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-1125_fd2fa2af-5929-4152-afd3-55e4e162f765
PRODUCT NDC: 55154-1125
APPLICATION NUMBER: NDA050578

Other CEFTAZIDIME SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthFORTAZ